Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma.
Polaki US, Gilpin TE, Patil AT, Chiu E, Baker R, Liu P, Pavletich TS, Seifi M, Mañán-Mejías PM, Morrissey J, Port J, Welch Schwartz R, Ong IM, El-Rayes D, Khalifa MA, Hui P, Horner VL, Virumbrales-Muñoz M, Erickson BK, Barroilhet L, McGregor SM, Bresnick EH, Matson DR.
Polaki US, et al. Among authors: matson dr.
JCI Insight. 2025 Apr 1;10(9):e187073. doi: 10.1172/jci.insight.187073. eCollection 2025 May 8.
JCI Insight. 2025.
PMID: 40168074
Free PMC article.